Mete
Antonio Mete, Leicestershire GB
Patent application number | Description | Published |
---|---|---|
20080293742 | Novel N-(Fluoro-Pyrazinyl)-Phenylsulfonamides as Modulators of Chemokine Receptor Ccr4 - The invention provides N-(fluoro-pyrazinyl)-phenylsulfonamides of formula (I) wherein R | 11-27-2008 |
20100029713 | QUINICLIDINE DERIVATIVES OF (HETERO) ARYLCYCLOHEPTANECARBOXYLIC ACID AS MUSCARINIC RECEPTOR ANTAGONISTS - The invention provides compounds of formula (I) wherein R | 02-04-2010 |
20100113510 | QUINUCLIDINOL DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS - The invention provides compounds of formula (I) wherein R | 05-06-2010 |
20100286118 | SUBSTITUTED 1-CYANOETHYLHETEROCYCLYLCARBOXAMIDE COMPOUNDS 750 - The present invention provides compounds of formula (I) | 11-11-2010 |
20110172237 | QUINUCLIDINE DERIVATIVES AS MUSCARINIC M3 RECEPTOR ANTAGONISTS - The invention provides named compounds of formula (I), wherein R4 is a N-substituted quinuclidine (I) pharmaceutical compositions containing them and a process for preparing the pharmaceutical compositions. Their use in therapy for’ the treatment of conditions mediated by M3 muscarinic receptors, such as chronic obstructive pulmonary disease is also disclosed. | 07-14-2011 |
20110190309 | PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONIST - The invention provides a pharmaceutical product, kit or composition comprising a first active ingredient which is a selected muscarinic receptor antagonist, and a second active ingredient which is a β | 08-04-2011 |
20120329775 | SUBSTITUTED 1-CYANOETHYLHETEROCYCLYLCARBOXAMIDE COMPOUNDS 750 - The present invention provides compounds of formula (I) | 12-27-2012 |
Antonio Mete, Loughborough GB
Patent application number | Description | Published |
---|---|---|
20100144759 | NOVEL N-(FLUORO-PYRAZINYL)-PHENYLSULFONAMIDES AS MODULATORS OF CHEMOKINE RECEPTOR CCR4 - The invention provides N-(fluoro-pyrazinyl)-phenylsulfonamides of formula (I) | 06-10-2010 |
Antonio Mete, Macclesfield GB
Patent application number | Description | Published |
---|---|---|
20130005695 | QUINICLIDINE DERIVATIVES OF (HETERO) ARYLCYCLOHEPTANECARBOXYLIC ACID AS MUSCARINIC RECEPTOR ANTAGONISTS - The invention provides compounds of formula (I) wherein R | 01-03-2013 |
20130030001 | QUINUCLIDINE DERIVATIVES AS MUSCARINIC M3 RECEPTOR ANTAGONISTS - The invention provides named compounds of formula (I), | 01-31-2013 |
Michael Mete, Santa Barbara, CA US
Patent application number | Description | Published |
---|---|---|
20130154211 | SKATEBOARD AND SKATEBOARD TRUCK - Devices and methods for lowering the center of gravity of a skateboard, while maintaining the structural integrity of the deck are described herein. In some embodiments, a skateboard includes a deck, a pair of trucks, and a set of bearings and wheels. The deck can include a cutout configured to receive a portion of the truck. The trucks are configured to couple to a bottom surface of the deck and include a portion disposed within the opening of the deck. | 06-20-2013 |
Michael T. Mete, Santa Barbara, CA US
Patent application number | Description | Published |
---|---|---|
20140306411 | SKATEBOARD AND SKATEBOARD TRUCK - Devices and methods for lowering the center of gravity of a skateboard, while maintaining the structural integrity of the deck are described herein. In some embodiments, a skateboard includes a deck, a pair of trucks, and a set of bearings and wheels. The deck can include a cutout configured to receive a portion of the truck. The trucks are configured to couple to a bottom surface of the deck and include a portion disposed within the opening of the deck. | 10-16-2014 |
Mutlu Mete, Little Rock, AR US
Patent application number | Description | Published |
---|---|---|
20080205776 | Image processing apparatus and method for histological analysis - An automated method for analyzing whether all cancerous or abnormal tissue has been removed as a result of surgical resection is disclosed. A number of tissue section slides are prepared representing all or a relatively large percentage of the tissue sample, and high-resolution digital microscopic images are formed of the sections. A clustering algorithm forms an image showing the healthy tissue margins, such representation being stored in a file of significantly smaller size than the original photograph. These two-dimensional image files may be formed into a three-dimensional image of the entire resected tissue, thereby improving the accuracy and ease by which a pathologist may determine if further surgery or radiation therapy, for example, are indicated. | 08-28-2008 |